Simulations Plus stock hits 52-week low at $23.99

Simulations Plus , Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical development, has seen its stock price touch a 52-week low, trading at $23.99. According to InvestingPro data, the stock’s RSI indicates oversold territory, while analysts maintain price targets ranging from $37 to $65. This latest price level reflects a significant downturn from the company’s performance over the past year, with the stock experiencing a 1-year change of -41.81%. Investors are closely monitoring the company’s financial health and market position, with InvestingPro data showing strong fundamentals including a healthy current ratio of 4.15 and impressive revenue growth of ~20% over the last twelve months. The 52-week low serves as a critical indicator for shareholders and potential investors, marking the lowest price point at which the stock has traded over the past year and setting a new benchmark for the company’s market valuation. InvestingPro analysis suggests the stock may be undervalued at current levels, with 12 additional exclusive ProTips available for subscribers.

In other recent news, Simulations Plus reported its fourth-quarter earnings for fiscal year 2024, surpassing Wall Street expectations with an earnings per share (EPS) of $0.17, compared to the forecast of $0.14. The company also reported total revenue of $18.9 million for the quarter, slightly above the anticipated $18.77 million, marking an 18% year-over-year increase to reach $70 million. The firm has maintained a strong financial position with no debt and $20 million in cash. KeyBanc Capital Markets raised its price target for Simulations Plus from $35.00 to $37.00, maintaining an Overweight rating, citing a positive outlook on the company’s valuation and growth prospects. Oppenheimer analysts also affirmed an Outperform rating with a $65.00 price target, following the company’s first-quarter fiscal year 2025 revenue report, which closely aligned with analyst expectations. Additionally, during the company’s recent Annual Meeting of Shareholders, several key proposals were approved, including the election of five board members and the ratification of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm. The company remains cautiously optimistic about its financial prospects for 2025, projecting total revenue between $90 million and $93 million, with an expected contribution from its recent Pro-ficiency acquisition.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.